Brodimoprim is a structural derivative of trimethoprim where the 4-methoxy group is replaced with a bromine atom. It is a dihydrofolate reductase inhibitor used as a pharmaceutical raw material.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Brodimoprim?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Trimethoprim
pharmaceutical raw material
7-keto-dehydroepiandrosterone
pharmaceutical raw material
5α-Dihydroprogesterone
pharmaceutical raw material
Cefmetazole
pharmaceutical raw material
Cefmetazole sodium
pharmaceutical raw material
5-(3,4-Dimethoxybenzyl)pyrimidine-2,4-diamine hydrochloride
pharmaceutical raw material
Diaveridine
pharmaceutical raw material
5-({3,5-Dimethoxy-4-[(²H₃)methyloxy]phenyl}methyl)pyrimidine-2,4-diamine
research compound
The international HS code for Brodimoprim (CAS 56518-41-3) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
5-[(4-bromo-3,5-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine
BFCRRLMMHNLSCP-UHFFFAOYSA-N
COC1=CC(=CC(=C1Br)OC)CC2=CN=C(N=C2N)N
Sourcing Brodimoprim?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.